| 000 | 01281 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516041001.0 | ||
| 264 | 0 | _c20120724 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1873-4316 | ||
| 024 | 7 |
_a10.2174/138920111798808266 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJaschinski, Frank | |
| 245 | 0 | 0 |
_aThe antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-β2. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical biotechnology _cDec 2011 |
||
| 300 |
_a2203-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOligodeoxyribonucleotides _xtherapeutic use |
| 650 | 0 | 4 |
_aThionucleotides _xtherapeutic use |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta2 _xantagonists & inhibitors |
| 700 | 1 | _aRothhammer, Tanja | |
| 700 | 1 | _aJachimczak, Piotr | |
| 700 | 1 | _aSeitz, Christian | |
| 700 | 1 | _aSchneider, Anneliese | |
| 700 | 1 | _aSchlingensiepen, Karl-Hermann | |
| 773 | 0 |
_tCurrent pharmaceutical biotechnology _gvol. 12 _gno. 12 _gp. 2203-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138920111798808266 _zAvailable from publisher's website |
| 999 |
_c20879939 _d20879939 |
||